| Metcash Limited (MTS) ORDINARY FULLY PAID |
Consumer Staple |
$3,288 |
Ceasing to be a substantial holder
|
29 Aug 2025 4:20PM |
$4.200 |
$2.990 |
fallen by
28.81%
|
|
| Kinatico Ltd (KYP) ORDINARY FULLY PAID |
Information Technology |
$66 |
Change in substantial holding
|
29 Aug 2025 4:20PM |
$0.275 |
$0.150 |
fallen by
45.45%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$17 |
Corporate Governance Statement and Appendix 4G
|
29 Aug 2025 4:19PM |
$2.350 |
$0.370 |
fallen by
84.26%
|
|
| Silex Systems Limited (SLX) ORDINARY FULLY PAID |
Industrials |
$1,490 |
Application for quotation of securities - SLX
|
29 Aug 2025 4:19PM |
$4.150 |
$5.350 |
risen by
28.92%
|
|
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Appendix 4E & Consolidated Financial Report
|
29 Aug 2025 4:19PM |
$0.014 |
$0.006 |
fallen by
57.14%
|
|
OMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 63.3% to $4,126,920.
- Net comprehensive loss rose to $1,905,398, up 18.3% from last year.
- No dividends were declared or paid in the reporting period.
- The acquisition of Good Oats Pty Ltd was completed.
- Net tangible assets per share improved slightly.
- The company adhered to international financial reporting standards.
- Equity contributions increased the company's capital base.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Appendix 4E & Consolidated Financial Report
|
29 Aug 2025 4:19PM |
$0.014 |
$0.006 |
fallen by
57.14%
|
|
OMG - Price-sensitive ASX Announcement
Full Release
Key Points
- OMG Group Limited reported a loss of $1.9 million for the year ended 30 June 2025.
- Acquired Good Oats Pty Ltd, enhancing revenue and synergies.
- Net assets increased significantly to $4.03 million.
- Equity contributions and share-based transactions boosted financial position.
- Successful $2.0 million capital raise announced in August 2025.
- Focus remains on inventory increase and e-commerce expansion.
- No dividends declared for the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$17 |
Annual Report to shareholders
|
29 Aug 2025 4:19PM |
$2.350 |
$0.370 |
fallen by
84.26%
|
|
| AuKing Mining Limited (AKN) ORDINARY FULLY PAID |
Materials |
$38 |
Change of Director's Interest Notices
|
29 Aug 2025 4:19PM |
$0.005 |
$0.018 |
risen by
260%
|
|
| USCOM Ltd (UCM) ORDINARY FULLY PAID |
Health Care |
$3 |
Preliminary Final Report
|
29 Aug 2025 4:18PM |
$0.011 |
$0.012 |
risen by
9.09%
|
|
UCM - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating revenue was AUD 2.58 million, with a notable decrease in product sales.
- Net loss after tax was AUD 3.30 million for the year.
- Significant share issuances and share-based payments were undertaken.
- The majority of revenue was generated from Asia and Australia.
- Ongoing strategies aim to improve operational performance and growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| USCOM Ltd (UCM) ORDINARY FULLY PAID |
Health Care |
$3 |
Preliminary Final Report
|
29 Aug 2025 4:18PM |
$0.011 |
$0.012 |
risen by
9.09%
|
|
UCM - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the year was AUD 2,578,793, down from AUD 3,726,845 in 2024.
- The company incurred a loss after tax of AUD 3,302,759.
- Total comprehensive loss for the year was AUD 3,285,358.
- Total liabilities increased to AUD 3,286,171 from AUD 2,073,575.
- Cash and cash equivalents at the end of the year were AUD 966,657.
- The company issued shares worth AUD 2,000,000 with associated transaction costs of AUD 86,001.
- Negative net assets of AUD (38,224) at the end of the financial year.
- Accumulated losses increased to AUD 44,881,078.
- Earnings per share declined to (1.8) cents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$244 |
Change of Director's Interest Notices x3
|
29 Aug 2025 4:17PM |
$0.300 |
$0.105 |
fallen by
65%
|
|
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 4:16PM |
$0.014 |
$0.006 |
fallen by
57.14%
|
|
| IODM Limited (IOD) ORDINARY FULLY PAID |
Information Technology |
$73 |
Appendix 4G
|
29 Aug 2025 4:16PM |
$0.100 |
$0.115 |
risen by
15%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$96 |
Notification of cessation of securities - CAM
|
29 Aug 2025 4:16PM |
$0.700 |
$0.680 |
fallen by
2.86%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$17 |
Appendix 4E - Preliminary Final Report
|
29 Aug 2025 4:16PM |
$2.350 |
$0.370 |
fallen by
84.26%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- EZZ Life Science Holdings Limited reported a profit for the year of $6,730,441 in 2025, compared to $6,964,488 in 2024.
- The company's net assets increased from $21,322,838 in 2024 to $28,085,315 in 2025.
- Share capital rose from $6,852,670 in 2024 to $8,736,775 in 2025 due to employee incentive schemes and performance rights exercises.
- The net tangible assets per ordinary security increased from 47.98 cents in 2024 to 59.49 cents in 2025.
- The company declared a final dividend of 2.00 cents per security, fully franked, payable in December 2024, and an interim dividend of 2.00 cents per security in 2025.
- The Appendix 4E report does not report any changes in control over entities or loss of control over any entity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$17 |
Appendix 4E - Preliminary Final Report
|
29 Aug 2025 4:16PM |
$2.350 |
$0.370 |
fallen by
84.26%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities increased by 0.65% to $66,873,691.
- Profit after tax attributable to owners decreased by 3.36% to $6,730,441.
- Net assets increased from $21,322,838 to $28,085,315.
- Share capital increased due to employee incentives and performance rights.
- Net tangible assets per security increased from 47.98 to 59.49 cents.
- Final dividend of 2.00 cents per security was paid on 9 December 2024.
- Interim dividend of 2.00 cents was paid on 17 June 2025.
- The financial statements were audited with an unmodified opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$91 |
Notification of cessation of securities - TOP
|
29 Aug 2025 4:14PM |
$0.690 |
$0.540 |
fallen by
21.74%
|
|
| Mammoth Minerals Limited (M79) ORDINARY FULLY PAID |
Materials |
$20 |
Notification regarding unquoted securities - M79
|
29 Aug 2025 4:14PM |
$0.120 |
$0.035 |
fallen by
70.83%
|
|
| IODM Limited (IOD) ORDINARY FULLY PAID |
Information Technology |
$73 |
Appendix 4E Annual Report FY25
|
29 Aug 2025 4:13PM |
$0.100 |
$0.115 |
risen by
15%
|
|
IOD - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing ordinary activities decreased by 94% to $4,000.
- Total income from continuing ordinary activities decreased by 47% to $532,000.
- Loss from continuing operations increased by 11% to $4,942,000.
- No dividend was declared for the current or previous corresponding period.
- Net tangible liabilities were reported at (0.2) cents per share.
- Net tangible liabilities per ordinary security remained stable at (0.2) cents.
- The company did not gain control over any new entities during the period.
- The report was compiled using the International Financial Reporting Standards (IFRS).
- The strategic focus is on the commercialisation of the Felix™ male fertility technology.
- Dr. Lindley Edwards was appointed as the Non-Executive Chairperson in November 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
FY25 Preliminary Results Summary and Company Update
|
29 Aug 2025 4:13PM |
$0.031 |
$0.036 |
risen by
16.13%
|
|
CDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Cardiex reported a 10% revenue increase in FY25.
- The company launched the Pulse product in H2 FY25.
- Operational cost reductions significantly lowered the annual expense base.
- Cash at hand by 30 June 2025 was $2.4 million, with more expected inflows.
- Net assets increased by 37% to $5.6 million.
- C2 Ventures confirmed full participation in the June Placement.
- The company is positioned to execute its FY26 growth strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mammoth Minerals Limited (M79) ORDINARY FULLY PAID |
Materials |
$20 |
Notification regarding unquoted securities - M79
|
29 Aug 2025 4:13PM |
$0.120 |
$0.035 |
fallen by
70.83%
|
|
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
FY25 Preliminary Results Summary and Company Update
|
29 Aug 2025 4:13PM |
$0.031 |
$0.036 |
risen by
16.13%
|
|
CDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Cardiex achieved a 10% revenue increase in FY25.
- The company's expense base was reduced to $10-12 million annually.
- Cardiex had $2.4 million in cash as of 30 June 2025.
- Expected further inflows from a June placement and R&D incentives.
- Net assets increased by 37% to $5.6 million.
- Support from C2 Ventures for future capital needs.
- New revenue streams from Pulse and Xcel products.
- Focus on executing FY26 growth strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Develop Global Limited (DVP) ORDINARY FULLY PAID |
Materials |
$2,105 |
Date of AGM and Closing Date for Director Nominations
|
29 Aug 2025 4:13PM |
$3.860 |
$6.380 |
risen by
65.28%
|
|
| Seafarms Group Limited (SFG) ORDINARY FULLY PAID |
Consumer Staple |
$10 |
SFG Preliminary Final Report FY25
|
29 Aug 2025 4:12PM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
SFG - Price-sensitive ASX Announcement
Full Release
Key Points
- Seafarms Group reported a net loss of $11.7 million for FY25.
- Total equity decreased significantly to $3.1 million by June 30, 2025.
- Accumulated losses reached $312 million at the end of the financial year.
- Operating activities resulted in a cash deficit of $9.7 million.
- Asset sales and borrowings were crucial for liquidity maintenance.
- Impairments were recorded on receivables and right-of-use assets.
- Significant legal and finance costs impacted financial results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$31 |
Notice Required Under ASX Listing Rule 3.13.1
|
29 Aug 2025 4:11PM |
$0.150 |
$0.260 |
risen by
73.33%
|
|
Call 1300 880 160
Start a chat
Schedule a call
